David Bionghi


David Bionghi focuses his practice on corporate and securities matters, primarily representing foreign and US issuers and investment banks in public and private corporate finance transactions. His experience includes working on initial public offerings, follow-on offerings, at-the-market offerings, special purpose acquisition company (SPAC)–related transactions, and mergers and acquisitions. David has advised companies in the finance, tech, healthcare, life science, biotechnology, and manufacturing industries. David also counsels public companies in connection with annual and quarterly reports, proxy statements, and compliance under US federal securities laws. He is admitted in New York and the District of Columbia only.